Cargando…

Binge eating disorder hidden behind a wall of anxiety disorders

Detalles Bibliográficos
Autores principales:	Pipe, Amy, Patterson, Beth, Van Ameringen, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Joule Inc. 2021
Materias:	Psychopharmacology for the Clinician
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061740/ https://www.ncbi.nlm.nih.gov/pubmed/33667054 http://dx.doi.org/10.1503/jpn200235

Ejemplares similares

To continue or discontinue antidepressants in anxiety disorders? A dilemma for patients and clinicians
por: Muntingh, Anna, et al.
Publicado: (2021)

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021)

Mindfulness-based intervention for benzodiazepine deprescription in hemodialysis patients with anxiety and depressive symptoms
por: Garel, Nicolas, et al.
Publicado: (2023)

Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness
por: van Reekum, Emma A, et al.
Publicado: (2023)

Oculogyric crisis: a rare type of dystonia
por: Boi, Sara, et al.
Publicado: (2021)

Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination
por: Thompson, Deborah, et al.
Publicado: (2021)

Use of MAOIs in severe treatment-resistant depression: back to the old school
por: Cookey, Jacob
Publicado: (2021)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Prescribing differently for women with first-episode psychosis
por: Sabesan, Priyadharshini, et al.
Publicado: (2021)

Atypical antipsychotics, dystonia, and psychotic depression: old solutions for new problems
por: Gazzellone, Matthew J., et al.
Publicado: (2022)

Medical assistance in living after failure of ECT and ketamine
por: Lafrenière, Simon, et al.
Publicado: (2022)

Use of repetitive transcranial magnetic stimulation in the treatment of catatonia
por: Licht, Christiane, et al.
Publicado: (2022)

Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023)

Clinical management of psychosis in 22q11.2 deletion syndrome
por: Iftimovici, Anton, et al.
Publicado: (2022)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Treatment of anxiety disorders in patients with comorbid bipolar disorder
por: Ott, Carol A.
Publicado: (2018)

Buspirone in obsessive-compulsive disorder: a potential dark horse?
por: Garg, Kabir, et al.
Publicado: (2021)

Multicentre evaluation of the pharmacological management of women with bipolar disorder in the perinatal period
por: Dias, Marisa Casanova, et al.
Publicado: (2021)

Management of treatment-resistant generalized anxiety disorder
por: Ansara, Elayne D.
Publicado: (2020)

Peripheral cortisol administration blunts reward arousal but heightens anxiety-like arousal in marmosets
por: Alexander, Laith, et al.
Publicado: (2021)

The Impact of Prophylactic Medication Use on the Recurrence of Bipolar Episodes in the BDRN Pregnancy Study
por: Dias, Marisa Casanova, et al.
Publicado: (2023)

Ambulatory detoxification in alcohol use disorder and opioid use disorder
por: Moore, Troy A.
Publicado: (2020)

Opioid use disorder in pregnancy
por: Harter, Kristin
Publicado: (2019)

Pharmacotherapy treatment of stimulant use disorder
por: Liu, Mei T.
Publicado: (2021)

Major depressive disorder in children and adolescents
por: Mullen, Sandra
Publicado: (2018)

Traumatic brain injury and mood disorders
por: Robert, Sophie
Publicado: (2020)

Developing a New Lithium Policy
por: Wong, Brandon, et al.
Publicado: (2023)

Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale – a healthcare improvement study in a geriatric ward setting
por: Balasundaram, Bharathi, et al.
Publicado: (2022)

A narrative review of the pharmacological management of psychosis in Alzheimer's disease
por: Matthews, Alexander, et al.
Publicado: (2021)

Testogel Application in the Menopause: Making a Difference to the Lives of Women
por: Heald, Adrian, et al.
Publicado: (2023)

Rapid Clozapine Blood Level Determination in a National Health Service Trust
por: Taylor, David, et al.
Publicado: (2023)

Assessment of Legibility and Completeness of Prescriptions at Tertiary Care Hospitals: A Cross-Sectional Study
por: Saeed, Sajeel, et al.
Publicado: (2022)

Challenges of Chemsex in Health, Justice, and Social Care Settings: Developing a Coordinated Response
por: Hillier, Bradley, et al.
Publicado: (2023)

The Effects of Rivastigmine on Neuropsychiatric Symptoms in the Early Stages of Parkinson's Disease: A Systematic Review
por: Reilly, Siobhan, et al.
Publicado: (2023)

Adjunct pharmacotherapy for psychotherapy
por: Lochtenberg, Jessica, et al.
Publicado: (2021)

Psilocybin: the magic medicine for depression?
por: Corrigan, Amber Elyse, et al.
Publicado: (2021)

Different onset patterns of monthly paliperidone palmitate in hospitalised patient diagnosed with schizophrenia
por: Herrera-Sánchez, Javier, et al.
Publicado: (2021)

Comparison between the efficiency of pharmacotherapy and cognitive behavioral therapy in reducing captagon (fenethylline) dependence and relapse prevention
por: Binnwejim, Mohammed, et al.
Publicado: (2021)

The links between the amount of antipsychotic medication prescribed at GP practice level, local demographic factors and medication selection
por: Heald, Adrian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kf5v6cdoq28jj7e1l9ljahvk48